{"id":"https://openalex.org/W7116385993","doi":"https://doi.org/10.1016/j.critrevonc.2025.105098","title":"Impact of adding immune checkpoint inhibitors to standard therapies in non-small cell lung cancer: A systematic review of efficacy outcomes","display_name":"Impact of adding immune checkpoint inhibitors to standard therapies in non-small cell lung cancer: A systematic review of efficacy outcomes","publication_year":2025,"publication_date":"2025-12-20","ids":{"openalex":"https://openalex.org/W7116385993","doi":"https://doi.org/10.1016/j.critrevonc.2025.105098","pmid":"https://pubmed.ncbi.nlm.nih.gov/41423066"},"language":"en","primary_location":{"id":"doi:10.1016/j.critrevonc.2025.105098","doi":"https://doi.org/10.1016/j.critrevonc.2025.105098","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.critrevonc.2025.105098","pdf_url":null,"source":{"id":"https://openalex.org/S185233701","display_name":"Critical Reviews in Oncology/Hematology","issn_l":"1040-8428","issn":["1040-8428","1879-0461"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Oncology/Hematology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102313991","display_name":"Ana Pinto Correia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ana Pinto Correia","raw_affiliation_strings":["Faculdade de Farm\u00e1cia, Universidade de Lisboa, Lisbon, Portugal; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMed.ULisboa), Lisbon, Portugal. Electronic address: analuisacorreia@edu.ulisboa.pt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculdade de Farm\u00e1cia, Universidade de Lisboa, Lisbon, Portugal; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMed.ULisboa), Lisbon, Portugal. Electronic address: analuisacorreia@edu.ulisboa.pt","institution_ids":["https://openalex.org/I141596103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120889130","display_name":"Adriana Marques","orcid":"https://orcid.org/0000-0002-0812-7669","observed_orcids":["https://orcid.org/0000-0002-0812-7669"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Adriana Marques","raw_affiliation_strings":["Faculdade de Farm\u00e1cia, Universidade de Lisboa, Lisbon, Portugal; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMed.ULisboa), Lisbon, Portugal. Electronic address: adriana.marques1@edu.ulisboa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculdade de Farm\u00e1cia, Universidade de Lisboa, Lisbon, Portugal; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMed.ULisboa), Lisbon, Portugal. Electronic address: adriana.marques1@edu.ulisboa","institution_ids":["https://openalex.org/I141596103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087016269","display_name":"Bruno Miguel Nogueira Sepodes","orcid":"https://orcid.org/0000-0002-2761-0955","observed_orcids":["https://orcid.org/0000-0002-2761-0955"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Bruno Sepodes","raw_affiliation_strings":["Faculdade de Farm\u00e1cia, Universidade de Lisboa, Lisbon, Portugal; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMed.ULisboa), Lisbon, Portugal. Electronic address: bsepodes@ff.ulisboa.pt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculdade de Farm\u00e1cia, Universidade de Lisboa, Lisbon, Portugal; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMed.ULisboa), Lisbon, Portugal. Electronic address: bsepodes@ff.ulisboa.pt","institution_ids":["https://openalex.org/I141596103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120890684","display_name":"Carla Torre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Carla Torre","raw_affiliation_strings":["Faculdade de Farm\u00e1cia, Universidade de Lisboa, Lisbon, Portugal; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMed.ULisboa), Lisbon, Portugal. Electronic address: carla.torre@ff.ulisboa.pt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculdade de Farm\u00e1cia, Universidade de Lisboa, Lisbon, Portugal; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMed.ULisboa), Lisbon, Portugal. Electronic address: carla.torre@ff.ulisboa.pt","institution_ids":["https://openalex.org/I141596103"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083171867","display_name":"Jo\u00e3o Pedro Rocha","orcid":"https://orcid.org/0000-0002-0303-8085","observed_orcids":["https://orcid.org/0000-0002-0303-8085"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]}],"countries":["PT"],"is_corresponding":true,"raw_author_name":"Jo\u00e3o Rocha","raw_affiliation_strings":["Faculdade de Farm\u00e1cia, Universidade de Lisboa, Lisbon, Portugal; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMed.ULisboa), Lisbon, Portugal. Electronic address: jrocha@ff.ulisboa.pt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculdade de Farm\u00e1cia, Universidade de Lisboa, Lisbon, Portugal; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMed.ULisboa), Lisbon, Portugal. Electronic address: jrocha@ff.ulisboa.pt","institution_ids":["https://openalex.org/I141596103"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5083171867"],"corresponding_institution_ids":["https://openalex.org/I141596103"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":null,"fwci":0.1002,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.13426937,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"218","issue":null,"first_page":"105098","last_page":"105098"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.030899999663233757,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.012299999594688416,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9430000185966492},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":1.0},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6489999890327454},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.8730000257492065},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.984000027179718},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6549999713897705},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.949999988079071},{"id":"https://openalex.org/keywords/egfr-mutant-lung-cancer","display_name":"EGFR-mutant lung cancer","score":0.8769999742507935},{"id":"https://openalex.org/keywords/histological-subtypes","display_name":"histological subtypes","score":0.6100000143051147},{"id":"https://openalex.org/keywords/disease-stage","display_name":"disease stage","score":0.9559999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7864000201225281},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.5029000043869019},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.476500004529953},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.44909998774528503},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42089998722076416},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.41100001335144043},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3993000090122223},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.3880000114440918},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.3707999885082245},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.37059998512268066},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.3377000093460083},{"id":"https://openalex.org/C2993769353","wikidata":"https://www.wikidata.org/wiki/Q7598360","display_name":"Standard of care","level":2,"score":0.3203999996185303},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3172999918460846},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3140000104904175},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3111000061035156},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.30820000171661377},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2782000005245209},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.274399995803833},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.27070000767707825},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.26669999957084656},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2660999894142151},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2632000148296356},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.25589999556541443},{"id":"https://openalex.org/C169382597","wikidata":"https://www.wikidata.org/wiki/Q21208025","display_name":"Programmed cell death 1","level":5,"score":0.25440001487731934}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.critrevonc.2025.105098","doi":"https://doi.org/10.1016/j.critrevonc.2025.105098","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.critrevonc.2025.105098","pdf_url":null,"source":{"id":"https://openalex.org/S185233701","display_name":"Critical Reviews in Oncology/Hematology","issn_l":"1040-8428","issn":["1040-8428","1879-0461"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Oncology/Hematology","raw_type":"journal-article"},{"id":"pmid:41423066","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41423066","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical reviews in oncology/hematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W2560438049","https://openalex.org/W2762777471","https://openalex.org/W2796582438","https://openalex.org/W2804812017","https://openalex.org/W2805354595","https://openalex.org/W2892640821","https://openalex.org/W2915871871","https://openalex.org/W2924289105","https://openalex.org/W2946386783","https://openalex.org/W3009099064","https://openalex.org/W3017322331","https://openalex.org/W3022512725","https://openalex.org/W3037506839","https://openalex.org/W3084622183","https://openalex.org/W3093317346","https://openalex.org/W3100650313","https://openalex.org/W3110814768","https://openalex.org/W3118615836","https://openalex.org/W3121907365","https://openalex.org/W3135378412","https://openalex.org/W3152729586","https://openalex.org/W3152878368","https://openalex.org/W3154805493","https://openalex.org/W3167668640","https://openalex.org/W3183409909","https://openalex.org/W3203821399","https://openalex.org/W3204380660","https://openalex.org/W3204952685","https://openalex.org/W3205648534","https://openalex.org/W3211577173","https://openalex.org/W4200417352","https://openalex.org/W4205454439","https://openalex.org/W4213085451","https://openalex.org/W4223502512","https://openalex.org/W4285140640","https://openalex.org/W4293237625","https://openalex.org/W4307814905","https://openalex.org/W4308179948","https://openalex.org/W4310943234","https://openalex.org/W4316810205","https://openalex.org/W4319068412","https://openalex.org/W4321436832","https://openalex.org/W4321457619","https://openalex.org/W4321748195","https://openalex.org/W4321789733","https://openalex.org/W4361004666","https://openalex.org/W4361268620","https://openalex.org/W4386253956","https://openalex.org/W4391035883","https://openalex.org/W4391091522","https://openalex.org/W4391743853","https://openalex.org/W4392859371","https://openalex.org/W4396686802","https://openalex.org/W4396859394","https://openalex.org/W4396915845","https://openalex.org/W4399153733","https://openalex.org/W4401742667","https://openalex.org/W4401862799","https://openalex.org/W4402297989","https://openalex.org/W4402543961","https://openalex.org/W4405249279","https://openalex.org/W4406290723","https://openalex.org/W4409540773"],"related_works":["https://openalex.org/W4391560409","https://openalex.org/W7162626462","https://openalex.org/W4386359866","https://openalex.org/W2911249025","https://openalex.org/W3035845224","https://openalex.org/W7143494473","https://openalex.org/W4223432197","https://openalex.org/W2987628800","https://openalex.org/W3146253175","https://openalex.org/W7131353423"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-12-21T00:00:00"}